search
drug regulators
Trends
- 1Americans Set to Lose Access to Canadian Prescription Drugs●Americans Are About to Lose Access to Prescriptions from Canada
US Customs is moving to block Americans from importing prescription drugs from Canada, a long-used workaround for high US medication prices, according to the Wall Street Journal. Many patients, particularly retirees and those without adequate insurance, rely on Canadian pharmacies for cheaper drugs like insulin, and the change could raise their costs sharply. Commenters are debating drug pricing policy and whether US regulators will address domestic prices alongside the import crackdown.
- 2Japan Weighs Tighter Rules for Regenerative Medicine Clinics▼Japan weighs tighter rules as regenerative medicine treatments spread
Japan is considering stricter regulations on regenerative medicine as treatments in the field proliferate across the country. The move follows growing concern that clinics are offering unproven therapies under looser rules than those governing conventional drugs. Officials are debating how to balance patient access to innovative treatments with safety oversight, and medical groups are watching closely for what the revised framework could mean for practice.
- 3Raw milk cheese recalled amid E. coli outbreak, FDA says▼Raw milk cheese recalled over E. coli outbreak, FDA says
US health regulators have announced a recall of raw milk cheese linked to an ongoing E. coli outbreak. The Food and Drug Administration says the cheese is suspected of making people ill, and retailers are being urged to pull affected products from shelves. News outlets across the country are carrying the recall notice, warning consumers who bought raw milk cheese to check products and avoid eating them while the investigation continues.
- 4After the Drug Laws: What Comes Next for Marijuana Policy●After the Drug Laws https://www.nytimes.com/2026/09/27/briefing/after-the-drug-laws.html # News # Marijuana # Law
The New York Times' briefing examines the aftermath of recent drug laws, focusing on marijuana policy and its legal consequences. The piece explores how changes in drug legislation are reshaping law enforcement, regulation and public attitudes. Readers are discussing the broader implications of these shifts for national drug policy.
- 5Platform Trials Are Rewriting the Rules of Medical Evidence●Platform Trials Are Rewriting the Rules of Evidence. Regulators Haven’t Caught Up.
Platform trials, which test multiple treatments against a single control group, are changing how clinical evidence is generated in medicine. Commentators argue that regulators have not yet adapted their standards to this trial design, raising questions about how such evidence will be assessed for drug approvals.
- 6FDA Commissioner nominee Heidi Overton grilled over independence from Trump●If Heidi Overton is confirmed as FDA Commissioner, what will she do if Trump asks her to take an action she knows is wrong? When @SenatorHassan questioned her, Overton refused to even entertain the possibility that Trump could be wrong. When it comes t
Heidi Overton, President Trump's nominee for FDA Commissioner, faced questioning from Senator Maggie Hassan at her confirmation hearing. Hassan pressed her on whether she would refuse an unlawful or improper directive from Trump, but Overton declined to entertain the possibility that the president could be wrong, drawing criticism that she would not commit to independent decision-making at the agency that regulates drugs and medical products.